NO993274D0 - Behandling av lupus nephritis med anti-CD40L-forbindelser - Google Patents

Behandling av lupus nephritis med anti-CD40L-forbindelser

Info

Publication number: NO993274D0
Authority: NO; Norway
Prior art keywords: treatment; lupus nephritis; cd40l compounds; cd40l; compounds
Prior art date: 1997-01-10

Application number

NO993274A

Other languages

English (en)

Other versions

NO993274L (no

Inventor

Susan L Kalled

David W Thomas

Original Assignee

Biogen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-10

Filing date

1999-07-01

Publication date

1999-07-01

1999-07-01 Application filed by Biogen Inc filed Critical Biogen Inc

1999-07-01 Publication of NO993274D0 publication Critical patent/NO993274D0/no

1999-09-10 Publication of NO993274L publication Critical patent/NO993274L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Mycology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Microbiology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO993274A 1997-01-10 1999-07-01 Behandling av lupus nephritis med anti-CD40L-forbindelser NO993274L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3467397P	1997-01-10	1997-01-10
PCT/US1997/023482 WO1998030240A1 (en)	1997-01-10	1997-12-31	Treatment of lupus nephritis with anti-cd40l compounds

Publications (2)

Publication Number	Publication Date
NO993274D0 true NO993274D0 (no)	1999-07-01
NO993274L NO993274L (no)	1999-09-10

Family

ID=21877889

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO993274A NO993274L (no)	1997-01-10	1999-07-01	Behandling av lupus nephritis med anti-CD40L-forbindelser

Country Status (19)

Country	Link
US (2)	US20030031668A1 (no)
EP (2)	EP0948355A1 (no)
JP (1)	JP2001508441A (no)
KR (2)	KR100618081B1 (no)
CN (2)	CN1572325A (no)
AU (1)	AU5709798A (no)
BR (1)	BR9714523A (no)
CA (1)	CA2277222A1 (no)
CZ (1)	CZ297680B6 (no)
EA (2)	EA006314B1 (no)
EE (1)	EE9900273A (no)
HU (1)	HUP0000833A3 (no)
IL (1)	IL130784A0 (no)
IS (1)	IS5100A (no)
NO (1)	NO993274L (no)
NZ (1)	NZ337072A (no)
PL (1)	PL190663B1 (no)
TR (7)	TR200001251T2 (no)
WO (1)	WO1998030240A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5474771A (en)	1991-11-15	1995-12-12	The Trustees Of Columbia University In The City Of New York	Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US7070777B1 (en)	1991-11-15	2006-07-04	The Trustees Of Columbia University In The City Of New York	Method for inhibiting inflammation with an antibody that binds the 5C8 protein
IL104684A0 (en)	1992-02-14	1993-06-10	Bristol Myers Squibb Co	The cd40cr receptor and ligands therefor
US6340459B1 (en)	1995-12-01	2002-01-22	The Trustees Of Columbia University In The City Of New York	Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipients
WO1999051258A1 (en) *	1998-04-03	1999-10-14	Trustees Of Dartmouth College	USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
IL126681A0 (en) *	1998-10-21	1999-08-17	Opperbas Holding Bv	Treatment of trauma-related conditions
US7553487B2 (en)	1998-12-14	2009-06-30	Genetics Institute, Llc	Method and compositions for treating asthma
AU780031B2 (en)	1998-12-14	2005-02-24	Genetics Institute, Llc	Cytokine receptor chain
US6171795B1 (en) *	1999-07-29	2001-01-09	Nexstar Pharmaceuticals, Inc.	Nucleic acid ligands to CD40ligand
AU2001249182A1 (en) *	2000-03-14	2001-09-24	Genetics Institute Inc.	Use of rapamycin and agents that inhibit b7 activity in immunomodulation
AU8867501A (en) *	2000-09-01	2002-03-13	Biogen Inc	Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
JP2004508420A (ja) *	2000-09-18	2004-03-18	アイデック　ファーマスーティカルズ　コーポレイション	Ｂ細胞枯渇抗体／免疫調節性抗体の組合せを用いて自己免疫疾患を治療するための併用療法
RU2487887C2 (ru)	2003-12-23	2013-07-20	Дженентек, Инк.	Новые анти-il 13 антитела и их использование
US7501121B2 (en)	2004-06-17	2009-03-10	Wyeth	IL-13 binding agents
AR049390A1 (es)	2004-06-09	2006-07-26	Wyeth Corp	Anticuerpos contra la interleuquina-13 humana y usos de los mismos
CN100369932C (zh) *	2005-04-07	2008-02-20	苏州大学	抗人cd154单克隆抗体及其应用
US8435514B2 (en)	2008-12-05	2013-05-07	Als Therapy Development Institute	Method for the treatment of neurodegenerative diseases
US9044459B2 (en)	2008-12-05	2015-06-02	Als Therapy Development Institute	Method for the treatment of neurodegenerative diseases
WO2012031122A2 (en) *	2010-09-03	2012-03-08	Immport Therapeutics, Inc.	Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders
KR102332302B1 (ko)	2013-09-13	2021-12-01	제넨테크, 인크.	세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
AU2014318615B2 (en)	2013-09-13	2020-03-12	Genentech, Inc.	Methods and compositions comprising purified recombinant polypeptides
WO2016029043A1 (en)	2014-08-21	2016-02-25	The General Hospital Corporation	Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same
MA41459A (fr)	2015-02-03	2017-12-12	Als Therapy Development Inst	Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l
JP2018526443A (ja) *	2015-08-31	2018-09-13	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	全身性エリテマトーデスを治療するためのｌｇａｌｓ３ｂｐの調節方法
CN110662768B (zh)	2017-05-24	2024-01-30	Als治疗发展学会	治疗性抗cd40配体抗体
KR20210095781A (ko)	2020-01-24	2021-08-03	주식회사 에이프릴바이오	항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
CA3209479A1 (en)	2021-02-03	2022-08-11	Mozart Therapeutics, Inc.	Binding agents and methods of using the same
WO2023076876A1 (en)	2021-10-26	2023-05-04	Mozart Therapeutics, Inc.	Modulation of immune responses to viral vectors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5474771A (en) *	1991-11-15	1995-12-12	The Trustees Of Columbia University In The City Of New York	Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US5876950A (en) *	1995-01-26	1999-03-02	Bristol-Myers Squibb Company	Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
US6440418B1 (en) *	1995-11-07	2002-08-27	Idec Pharmaceuticals Corporation	Methods of treating autoimmune diseases with gp39-specific antibodies
AU1748897A (en) *	1996-01-16	1997-08-11	Biogen, Inc.	Therapeutic applications of T-BAM (CD40-L) technology to treat inflammatory kidney diseases
WO1997034473A1 (en) *	1996-03-21	1997-09-25	The Trustees Of Columbia University In The City Of New York	Craf1 (traf-3) isoforms and uses thereof

1997
- 1997-12-31 TR TR2000/01251T patent/TR200001251T2/xx unknown
- 1997-12-31 TR TR1999/02191T patent/TR199902191T2/xx unknown
- 1997-12-31 EA EA199900636A patent/EA006314B1/ru not_active IP Right Cessation
- 1997-12-31 BR BR9714523-8A patent/BR9714523A/pt not_active Application Discontinuation
- 1997-12-31 CN CNA2004100353620A patent/CN1572325A/zh active Pending
- 1997-12-31 JP JP53090198A patent/JP2001508441A/ja not_active Ceased
- 1997-12-31 PL PL97334495A patent/PL190663B1/pl not_active IP Right Cessation
- 1997-12-31 TR TR2000/01247T patent/TR200001247T2/xx unknown
- 1997-12-31 KR KR1020057013113A patent/KR100618081B1/ko not_active IP Right Cessation
- 1997-12-31 CZ CZ0244499A patent/CZ297680B6/cs not_active IP Right Cessation
- 1997-12-31 TR TR2000/01246T patent/TR200001246T2/xx unknown
- 1997-12-31 TR TR2000/01249T patent/TR200001249T2/xx unknown
- 1997-12-31 TR TR2000/01248T patent/TR200001248T2/xx unknown
- 1997-12-31 WO PCT/US1997/023482 patent/WO1998030240A1/en active IP Right Grant
- 1997-12-31 EP EP97953325A patent/EP0948355A1/en not_active Withdrawn
- 1997-12-31 EA EA200501076A patent/EA200501076A1/ru unknown
- 1997-12-31 AU AU57097/98A patent/AU5709798A/en not_active Abandoned
- 1997-12-31 NZ NZ337072A patent/NZ337072A/xx unknown
- 1997-12-31 TR TR2000/01250T patent/TR200001250T2/xx unknown
- 1997-12-31 CA CA002277222A patent/CA2277222A1/en not_active Abandoned
- 1997-12-31 CN CN97181948A patent/CN1247472A/zh active Pending
- 1997-12-31 EP EP03014404A patent/EP1357131A3/en not_active Withdrawn
- 1997-12-31 KR KR1019997006253A patent/KR20000070034A/ko not_active Application Discontinuation
- 1997-12-31 IL IL13078497A patent/IL130784A0/xx unknown
- 1997-12-31 HU HU0000833A patent/HUP0000833A3/hu unknown
- 1997-12-31 EE EEP199900273A patent/EE9900273A/xx unknown
1999
- 1999-06-30 IS IS5100A patent/IS5100A/is unknown
- 1999-07-01 NO NO993274A patent/NO993274L/no not_active Application Discontinuation
2002
- 2002-09-27 US US10/260,639 patent/US20030031668A1/en not_active Abandoned
2006
- 2006-09-25 US US11/527,700 patent/US20070190053A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL334495A1 (en)	2000-02-28
US20070190053A1 (en)	2007-08-16
EE9900273A (et)	2000-02-15
US20030031668A1 (en)	2003-02-13
IS5100A (is)	1999-06-30
NZ337072A (en)	2000-12-22
KR20000070034A (ko)	2000-11-25
TR200001246T2 (tr)	2000-07-21
HUP0000833A3 (en)	2001-09-28
EP1357131A2 (en)	2003-10-29
IL130784A0 (en)	2001-01-28
TR200001247T2 (tr)	2002-06-21
JP2001508441A (ja)	2001-06-26
NO993274L (no)	1999-09-10
KR100618081B1 (ko)	2006-08-30
KR20050089165A (ko)	2005-09-07
TR200001248T2 (tr)	2000-07-21
TR200001250T2 (tr)	2001-03-21
CN1572325A (zh)	2005-02-02
BR9714523A (pt)	2000-05-02
EA200501076A1 (ru)	2006-06-30
CZ244499A3 (cs)	1999-10-13
TR200001251T2 (tr)	2000-09-21
EP1357131A3 (en)	2004-02-11
CN1247472A (zh)	2000-03-15
PL190663B1 (pl)	2005-12-30
CA2277222A1 (en)	1998-07-16
WO1998030240A1 (en)	1998-07-16
EP0948355A1 (en)	1999-10-13
AU5709798A (en)	1998-08-03
EA199900636A1 (ru)	2000-02-28
TR200001249T2 (tr)	2000-11-21
TR199902191T2 (xx)	1999-12-21
CZ297680B6 (cs)	2007-03-07
HUP0000833A2 (en)	2000-07-28
EA006314B1 (ru)	2005-10-27

Publication	Publication Date	Title
NO993274L (no)	1999-09-10	Behandling av lupus nephritis med anti-CD40L-forbindelser
DK0861081T3 (da)	2002-05-27	Anvendelse af epinastin til behandling af smerter
NO20012995L (no)	2001-08-15	Forbindelser nyttige for behandling av inflammatoriske sykdommer
PT1135391E (pt)	2004-07-30	Novos compostos de tiazolo(4,5-d)pirimidina
ID29021A (id)	2001-07-26	Komposisi galantamina pelepasan terkontrol
DK0664957T3 (da)	1996-12-16	Behandling af fjerkræ
NO20001479L (no)	2000-03-22	Behandling av atferdsforstyrrelse
DE69902223D1 (de)	2002-08-29	Polyfunktionelle organosilan behandlung von kieselsäure
NO20003065D0 (no)	2000-06-15	Kombinasjon for effektiv behandling av impotens
NO20011083L (no)	2001-05-03	Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH
NO960179D0 (no)	1996-01-15	Anvendelse av indenoindolforbindelser
IS4789A (is)	1998-06-30	Meðferðarefnasambönd
GB9701674D0 (en)	1997-03-19	Use of organic compounds
NO996545L (no)	2000-02-28	Behandling av aluminiumslagg
DE69433141D1 (de)	2003-10-16	Zusammensetzungen aus kohleteerschlamm
NO20010390D0 (no)	2001-01-23	Behandling av angstsykdommer
NO982562D0 (no)	1998-06-04	Sammensetning for behandling av smerte
NO993549L (no)	1999-09-21	Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no)	2000-05-12	Kombinasjonsterapi for behandling av AIDS
NO20003529D0 (no)	2000-07-07	Behandling av dyskinesi
PT1175417E (pt)	2004-04-30	Compostos substituidos de benzolactamas
NO20022244L (no)	2002-07-03	Behandling av SLE med dehydroepiandrosteron
FI963617A (fi)	1996-10-31	Ei-toivottujen halogenoitujen orgaanisten yhdisteiden käsittely
IL117813A0 (en)	1996-08-04	Use of heterocyclic compounds
NO20000274D0 (no)	2000-01-19	Behandling av fluider

Legal Events

Date	Code	Title	Description
2008-02-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application
2008-04-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application